Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
180 Cards in this Set
- Front
- Back
CO= ____ x______
|
HR x SV
|
|
A 57 year old male began taking a drug to dilate his arteries. Which of the following parameters will DECREASE?
-Preload -Afterload -Myocardial Contractility |
Afterload
|
|
If you increase preload, you _______ CO
|
increase
|
|
This is described as the amount of myocardial stretch at the end of diastole
|
preload
|
|
under steady state conditions, CO and Venous Return are ________.
|
equal
|
|
CO= ____ x______
|
HR x SV
|
|
A 57 year old male began taking a drug to dilate his arteries. Which of the following parameters will DECREASE?
-Preload -Afterload -Myocardial Contractility |
Afterload
|
|
If you increase preload, you _______ CO
|
increase
|
|
This is described as the amount of myocardial stretch at the end of diastole
|
preload
|
|
under steady state conditions, CO and Venous Return are ________.
|
equal
|
|
This is defined as Resistance the ventricles must overcome
to empty its contents |
Afterload
|
|
Increase PVR--> _______ afterload
|
increased
|
|
What effect will afterload have on the heart? (Starling Curve)
|
Lowers the curve
|
|
This is defined as the ability of the heart to develop contractile force
|
Contractility
|
|
Changes in contractility shift the Starling Curve _____________
|
up or down
|
|
what effect will myocardial damage from an MI have on the Starling Curve?
|
Shifts curve down
|
|
A 65 yr old man with HF is started on a β blocker. What does this do to his Staling curve?
|
Raises it!!
Remember, his HF originally lowered it! |
|
What happens to CO when a person excercises? What about a person with HF?
|
In a healthy person the CO increases to meet physiological needs
A person with HF can not increase their SV and thus CO to meet physiological needs |
|
With systolic and/or diastolic dysfunction, you have a _________ CO
|
decreased
|
|
What happens to blood pressure and perfusion of vital organs if CO is decreased?
|
↓BP
↓Perfusion --> organ failure |
|
What is the body's response to ↓CO?
|
Increase RAAS
Increase SNS Both will INCREASE BP |
|
How does activating the RAAS increase BP?
|
Kidneys: Increased Na+ and water retention
Arteries and veins: Vasoconstriction |
|
In the long-run, the body's compensatory actions to incease BP and CO cause ________ and ________
|
**more damage (↑afterload, ↑HR, ↑Force of contraction)
**edema (↑preload) |
|
In patients with heart failure, ↑ preload causes
|
little effect on CO, instead it causes MORE EDEMA
|
|
Excess neurohormones such as NE, Ang II and Aldosterone cause _________
|
cardiac remodeling
(hypertrophy, ventricular dilation, fibrosis, ect...) |
|
Heart failure patients at home are said to have _________ chronic heart failure
|
Stable chronic heart failure
|
|
Patients experiencing worsening HF and being admitted to a hospital have __________
|
Acute Decompensation
|
|
What are the two types of heart failure?
|
Stable Chronic Heart Failure
Acute Decompensation |
|
A patient whose symptoms of heart failure can be controlled by drugs has __________________.
|
Stable Chronic HF
|
|
A patient whose HF progresses, or something triggers a "relapse". Symptoms of pulmonary congestion and/or low CO
|
Acute Decompensation
|
|
What are the goals of treating HF?
|
Improve EF
Symptomatic relief of pulmonary edema Reduce Cardiac Remodeling REDUCE MORTALITY |
|
How can you ↑EF in a patient with Heart Failure?
|
↑Contractility (+ionotropic drugs)
Reduce afterload (arterial dilators) |
|
What drug classes can you use to reduce preload?
|
Diuretics
Venous Dilators |
|
List the stages of Heart Failure
|
Stage A
-High risk of developing HF but no structural disorder Stage B -Structural Disorder but no symptoms Stage C -Symptoms of HF assoc. w/ underlying heart disease Stage D -End stage disease who requires specialized support |
|
A 68 year old female patient has high risk for developing HF (atherosclerosis, diabetes mellitus), but does not have a structural disorder (eg. no LVH). What will we use to treat her HF?
|
Stage A
ACE INHIBITOR/ ARB |
|
"-pril"
|
ACE INHIBITORS
|
|
What effect will ACE Inhibitors have on arteries?
|
Vasodilation --> ↓Afterload --> ↑SV -->↑CO
|
|
What effect will ACE Inhibitors have on plasma volume?
|
↓Plasma volume by ↓Aldosterone
↓Ang II ↓ ↓Aldosterone ↓ ↓Na+ and water retention ↓ ↓preload |
|
What's the problem with ACE Inhibitors and the edema associated with HF?
|
Na+ and water loss with ACE Inhibitors is not sufficient to reduce edema assoc. w/ HF
|
|
After several months of tx with ACE Inhibitors, what happens to aldosterone levels?
|
They increase
|
|
High levels of Ang II lead to _______
|
Cardiac Hypertrophy and Remodeling
|
|
What drugs prevent or reverse cardiac hypertrophy and remodeling?
|
ACE Inhibitors
|
|
What are the benefits of using ACE Inhibitors in heart failure?
|
- ↓ afterload
-may ↓ preload **PREVENT CARDIAC REMODELING** |
|
All patients with heart failure due to LEFT VENTRICULAR SYSTOLIC DYSFUNCTION should receive __________
|
ACE Inhibitors
|
|
What stages of HF can ACE Inhibitors treat?
|
Stages A-D
NYHA I-IV |
|
What symptoms and lab tests would prevent you from using an ACE Inhibitor in a patient with HF?
|
HIGH creatinine
Low BP (hypotension) |
|
Adverse Effects
What are the biggest concerns when using an ACE Inhibitor in a pt. with HF? |
Hypotension
Worsening Renal Fxn Hyperkalemia |
|
"-sartan"
|
Angiotension Receptor Blockers
|
|
MOA: ARBs
|
Inhibit formation of Ang II
DOES NOT EFFECT Bradykinin |
|
Advantages of using ARBs to treat HF?
|
No/less cough or angioedema
|
|
A female patient recently had an echocardiogram and unfortunately, she now has LVH and a reduced ejection fraction. Otherwise, she feels good. What would you use to treat her HF?
|
Stage B
Still use ACE Inhibitors ADD A β BLOCKER |
|
Which β- BLOCKERS are used to treat HF?
|
Metroprolol
Bisoprolol Carvedilol These have been proven in clinical trials!! |
|
Metoprolol and Bisoprolol are what?
|
β1- BLOCKERS
"BEAM" |
|
What receptors does Carvedilol block?
|
β1, β2, α1
|
|
MOA: β- BLOCKERS for HF
|
unknown
|
|
With the use of β- BLOCKERS, ________________ is thought to contribute to mortality
|
Over stimulation of SNS
|
|
Overstimulation of the SNS can ultimately lead to what?
What other things can happen? |
CARDIAC REMODELING
-Down regulation of β1 receptors -Increased renin release -Na+ and water retention -Tachycardia and arrythmias |
|
MOA in HF:
Prevent or reverse cardiac remodeling Prevent atrial/ventricular arrythmias |
β- BLOCKERS
|
|
Are β- BLOCKERS negative ionotropic or positive ionotropic?
|
negative ionotropic
|
|
These agents:
-↑ LV Ejection Fraction** -↓ Ventricular volume - ↓ symptoms of HF -↓ Hospitalization for worsening HF -↓mortality |
β- BLOCKERS
|
|
This drug should be used in:
-Pt's with asymptomatic LV systolic dysfunction -Stage B -All patients with a hx of MI -All patients with a reduced Ejection Fraction |
β- BLOCKERS
|
|
Should you start a patient with Acute Decompensation a β- BLOCKER?
|
NO!
Only use β- BLOCKERS in Stable Chronic HF |
|
What stages and classes of HF can β- BLOCKERS be used in?
|
Stages B-D
NYHA Class I-IV |
|
Can β- BLOCKERS be used in all stage D patients?
|
NO
Patients with severe HF might not tolerate β- BLOCKERS They are negative ionotropes and will cause more harm than good |
|
You are about to start a β- BLOCKER in a patient with Stable Chronic HF. How would you dose it?
|
Start low, go slow
Since β's are negative ionotropes they might make the pt. worse at first until the body adjusts |
|
What is the initial dose for Metoprolol in patients with HF. What would you bump it up to over time?
|
Initial Dose: 25mg
Target Dose: 200mg or highest tolerated dose |
|
What would happen if a patient with NYHA Class II heart failure started therapy with 200mg of metoprolol?
|
They would DIE
Start low, go slow |
|
Can you use β- BLOCKERS in patients with HF and Diabetes?
|
Yes, diabetes IS NOT a contraindication
|
|
β- BLOCKERS should be used in conjunction with __________
|
ACEi's
|
|
Which β- BLOCKERS are FDA approved for HF?
|
Carvedilol and Metoprolol
|
|
A HF patient has mild symptoms that are controlled with enalapril and furosemide. Should a β- BLOCKER be added to their regimen?
|
YES
Reduce risk of: -Disease progression -Clinical deterioration -Sudden death |
|
Your HF patient ran out of β- BLOCKERS two days ago and has yet to re-fill the Rx. Is this a bad thing?
|
YES
Abrupt withdrawal can cause cardiac deterioration |
|
Adverse effects of β- BLOCKERS?
|
-Fluid retention and worsening HF
**Initiation of therapy or increasing dose** -Fatigue -Bradycardia and Heart Block -Hypotension |
|
If a patient has symptomatic bradycardia or a heart block w/o a pacemaker should you start them on β- BLOCKERS?
|
NO
Contraindicated |
|
Are fixed airway diseases (COPD) and diabetes contraindications for β- BLOCKER therapy in HF patients?
|
COPD: not necessarily contraindicated
Diabetes: NOT contraindicated |
|
Your HF patient has asthma and uses albuterol. Should you start β- BLOCKER therapy?
|
NO
Contraindicated |
|
What do you do when a patient with HF that has been taking β- BLOCKERS presents at the hospital with Acute Decompensation?
|
Keep them on β- BLOCKERS
Stop or reduce β- BLOCKERS ONLY in pt's hospitalized after recent initiation or up titration with marked overload |
|
Your patient's HF is getting worse because she just ad an episode of pulmonary edema. Before this, she had LVH and a reduced EF. What will you use to treat her?
|
She is in Stage C
ACEi β- BLOCKERS Loop Diuretics |
|
What is furosemide's action in HF?
|
Increases Na+ excretion
It counteracts Na+ and water RETENTION that occurs with HF |
|
What effect will using a Diuretic in a pt. with HF have on preload?
|
DECREASED PRELOAD
|
|
if you decrease preload, what happens to edema?
|
EDEMA DECREASES
|
|
What effect do diuretics have on CO in a pt. with HF?
**EXAM** |
Little to none
Since the curve is flat in HF, diuretics don't affect CO |
|
Which drugs are best to reduce pulmonary and peripheral edema without adversely affecting CO?
|
Diuretics
|
|
Which class of diuretic is most useful in the tx of edema accosiated with HF?
|
Loop Diuretics
|
|
Would you use a thiazide or loop diuretic in Stages A or B?
|
No, Stages A and B are asymptomatic and diuretics aren't called for
|
|
Would you use a diuretic to treat edema in Stages C and D of HF?
|
Yes
Mainly use loops Add a thiazide if refractory to Loop (potentiate effects) |
|
What drugs are the only ones to adequately control fluid retention in HF?
|
Loop and Thiazide Diuretics
|
|
Adverse effects of Loop and Thiazide Diuretics?
|
-Volume depletion
-Hypotension -Worsening renal fxn** -Hypokalemia (esp. in combo w/ Digoxin) |
|
What is one of the major problems associated with K+ depletion?
|
Arrythmias
|
|
How would you prevent hypokalemia associated with Loop and Thiazide diuretics?
|
K+ Sparing Diuretics
|
|
How does the activation of RAAS effect aldosterone levels
|
aldosterone levels increase
|
|
Levels of aldosterone can be 20X greater in patients with HF. What should we worry about with high aldosterone levels?
|
Vascular Injury
Cardiac Remodeling |
|
It is thought that blocking aldosterone receptors in the heart/blood vessels is _________
|
Cardioprotective
|
|
Your patient is on drugs that gives him an increased risk of developing hypokalemia. What drug can you add that has been proven to reduce the risk of hypokalemia?
|
Spironolactone DECREASES RISK OF HYPOKALEMIA
Decreases Mortality Decreases hospitalization for HF |
|
When adding Spironolactone to a pt.'s HF regimen what 2 things must you monitor?
|
Renal Function
K+ concentrations --> Hyperkalemia |
|
What Stages and NYHA classes is spironolactone recommended in?
|
Stage C
NYHA III-IV |
|
Levels of aldosterone can be 20X greater in patients with HF. What should we worry about with high aldosterone levels?
|
Vascular Injury
Cardiac Remodeling |
|
It is thought that blocking aldosterone receptors in the heart/blood vessels is _________
|
Cardioprotective
|
|
Your patient is on drugs that gives him an increased risk of developing hypokalemia. What drug can you add that has been proven to reduce the risk of hypokalemia?
|
Spironolactone DECREASES RISK OF HYPOKALEMIA
Decreases Mortality Decreases hospitalization for HF |
|
When adding an ALDOSTERONE RECEPTOR BLOCKER to a pt.'s HF regimen what 2 things must you monitor?
|
Renal Function
K+ concentrations --> Hyperkalemia |
|
What Stages and NYHA classes are ALDOSTERONE RECEPTOR BLOCKERS recommended in?
|
Stage C
NYHA III-IV |
|
These drugs should be used in pt's with moderately severe to severe HF and recent decompensation or with LV dysfunction early after an MI
|
ALDOSTERONE RECEPTOR BLOCKERS
Spironolactone Eperlenone |
|
A pt has Stage C, NYHA Class III HF. If their serum creatinine is >2.5 mg/dl (normal 08.-1.2mg/dl) would you use an ALDOSTERONE RECEPTOR BLOCKER?
|
NO
Creatinine is too high |
|
A pt has Stage C, NYHA Class III HF. If their serum K+ is >5.0 mEq/L (normal 3.5-5.0) would you use an aldosterone blocker?
|
NO
K+ is too high |
|
When using an aldosterone receptor blocker, what are the guidelines to minimize the threat of hyperkalemia?
|
Serum Cr < 2.0 female, < 2.5 male
Serum K+ < 5.0 |
|
What is an advantage of using eperlenone vs. spironolactone
|
Eperlenone doesn't block androgen/progesterone receptors
|
|
Adverse affects of this drug class include:
Fluid depletion Renal dysfxn Hperkalemia Gynomastasia |
Aldosterone Receptor Blockers
Note: Use of spironolactone can cause gynomastasia, not eperlenone |
|
You have a HF patient that complains of being fatigued with short walks. She has had to go to the hospital several times for her HF. She is on an ACEi, β- BLOCKER, Loop Diuretic, and Aldosterone Blocker. What drug will you add to help?
|
She's in Stage C
Add Digoxin |
|
What drug class is Digoxin in?
|
Digitalis Glycosides
|
|
What does digoxin inhibit?
|
It inhibits the Na/K ATPase in the cardiomyocyte
|
|
What type of ionotropic effect does digoxin have?
|
Positive Ionotropic Effect
|
|
MOA: Digoxin
|
Inhibits Na/K ATPase
Higher [Na+] causes less Ca++ to be lost from the cell by the Na/Ca exchanger More Ca++ taken up by SR Larger Ca++ gradient created Increased force of contraction |
|
If a patient has hyperkalemia, Digoxin is _________________
|
Less likely to bind to Na/K ATPase
It is thought that K and Digoxin compete for the same receptor |
|
Hypokalemia will (increase/decrease) Digoxin's effect/toxicity
|
Increase
|
|
What class of drugs can cause hypokalemia?
|
Loop and thiazide diuretics
|
|
What are Digoxin's indirect effects (2)? What do they cause?
|
1) increases vagal activity
2) Sensitizes baroreceptors and decreases SNS These 2 effects DECREASE ACTIVITY of SA and AV Nodes |
|
What effect does digoxin have on neurohormonal activity in HF patient?
|
Decreases Neurohormonal Activity
|
|
TOXIC EFFECTS
Lower doses of Digoxin cause ________________ |
Sinus bradycardia
AV Block |
|
TOXIC EFFECTS
Higher doses of Digoxin cause ______________ |
Increased SNS tone
Ca++ overload |
|
How does Digoxin cause Ca++ overload?
|
Digoxin prevents Ca++ efflux
|
|
Calcium overload can lead to what?
|
Arrythmias
|
|
In a damaged heart, what can excessive SNS tone and Ca++ overload cause?
|
Arrythmias
|
|
Digoxin has a low therapeutic index. What does this mean?
|
There's not a big difference between effective and toxic doses
|
|
This drug has NO effect on mortality but is used for symptomatic relief in stages C and D of HF
|
Digoxin
|
|
This drug treats Atrial fibrillation/flutter
|
Digoxin
|
|
How does digoxin decrease Atrial Fib/flutter?
|
Increases vagal tone
Slows ventricular rate **Doesn't get rid of A-fib/flutter but it CONTROLS it** |
|
An adverse effect of this drug is arrythmias of any type
|
Digoxin
|
|
Excessive vagal tone with use of Digoxin can cause __________(2)
|
Sinus bradycardia
AV Block |
|
Excessive Ca++ overload and Central SNS tone with use of Digoxin can cause _____________(3)
|
A-tachycardia
PVCs V-tachycardia & V-Fib |
|
What is normally the first sign of digoxin toxicty?
|
GI PROBLEMS
-NVD -Anorexia |
|
Other than GI problems, another early sign of Digoxin toxicity is _________
|
CNS Problems
Headache, Fatigue, Disorientation, Drowsiness, Confusion, Hallucinations |
|
This drug may cause visual disturbances and gynecomastia
|
Digoxin
|
|
What factors enhance Digoxin toxicity?
|
Hypokalemia
Hypercalcemia Hypomagnesemia (Mg++ inhibits K+ influx) |
|
What is the Digoxin "antidote"?
|
Digoxin Immune Fab
(Digibind) Fab fragment of digoxin-specific antibody |
|
How does Digoxin Immune Fab (Digibind) affect digoxin?
|
Binds digoxin in blood
Decreases amount of Digoxin that can bind and inhibit Na/K ATPase Digoxin-Digibind complex is excreted by kidney |
|
What do you use in life-threatening cases of Digoxin toxicity?
|
Digibind
|
|
Your Stage C HF patient's serum creatinine has been increasing. Further testing reveals renal artery stenosis. She is on an ACEi, Beta Blocker, Digoxin and a Loop Diuretic. What will you use to treat her HF?
|
remove ACEi --> Renal a. stenosis
ADD a Vasodilator |
|
What oral Vasodilators are used for HF?
|
Isosorbide Dinatrate
Hydralazine |
|
How does Isosorbide Dinitrate lower preload to treat HF?
|
it Vasodilates Veins
|
|
How does hydralazine lower afterload to treat HF?
|
Dilates arteries
|
|
What decreases mortality of african american HF pt's on optimal therapy with a diuretic, ACEi, and Beta Blocker?
|
Isosorbide Dinitrate + Hydralazine
|
|
Your Stage C heart failure pt cannot tolerate ACEi's or ARB's, what should you use to help decrease mortality?
|
Isosorbide Dinitrate + Hydralazine
|
|
Is the use of Isosorbide Dinitrate + Hydralazine (BiDil) as effective as ACEi's for Stage C HF?
|
No
|
|
What is the goal of drug treatment of Acute Decompensated HF?
|
Relieve Pulmonary Edema
Decrease Pump failure (Poor CO) |
|
What are two ways CO can be increased?
|
Reduce afterload
Increase contractility |
|
what are 2 ways to reduce preload?
|
Decrease Blood Volume
Venous Dilator |
|
What can you dilate to reduce afterload?
|
arteries
|
|
What are the IV drugs for Acute Decompensated HF?
|
-Loop Diuretics
-Nitroglycerin -Nitroprusside -Nesiritide |
|
When given to treat pulmonary edema in Acute Decompensation HF, what is the MOA of Loop Diuretics?
|
Vasodilation --> Increase SVC --> decrease LVP --> reduce pulm. edema
**when given by IV, Loops Vasodilate** |
|
What do you have to be concerned about when using Loop Diuretics for decompensated HF?
|
Excessive diuresis**
Hypotension Electrolyte disturbances Worsen renal fxn |
|
What is the best choice for treating pulmonary edema in a patient with acute decompensated HF?
|
Loop Diuretic
|
|
Nitroglycerin increases NO in _____
|
Veins
|
|
Nitroprusside increases NO in __________
|
Arteries and Veins
|
|
What will nitroglycerin and nitroprusside do to preload?
|
Decrease preload
|
|
What effect will nitroglycerine and nitroprusside have on afterload?
|
nitroprusside= Decreased afterload
nitroglycerine= not much of an effect |
|
This compound is released by ventricles in response to wall stress, hypertrophy and volume overload
|
B-type natriuretic peptide
|
|
What types of effects will Nesiritide have when compared to Ang II ?
|
opposite effects
|
|
MOA: Nesiritide
|
Activates Gaunylyl cyclase on vascular smooth m. cells
Increases cGMP Dilates arteries and Veins |
|
Nesiritide ________ afterload and preload by vasodilating arteries and veins
|
decreases
|
|
MOA: Nesiritide in Kidney
|
Blocks Na+ reabsorption
Consticts efferent arteriole and Dilates afferent arteriole --> Increased GFR |
|
What drugs are added to diuretics for pt's with evidence of severely symptomatic fluid overload in the absence of systemic HYPOtension?
|
IV Drugs for Acute Decompensation
-Nitroglycerin -Nitroprusside -Nesiritide |
|
What are the side effects of Nesiritide?
|
Hypotension
Headache |
|
Is Nesiritde approved for intermittent (weekly) IV infusion?
|
NO
|
|
In patients with Stage D HF, how can CO be increased?
|
Increase Contractility
|
|
Inamrinone and Milrinone inhibit what?
|
PDE-3
|
|
Other than Digoxin, what are some other positive ionotropic drugs you can use for Stage D HF?
|
Dobutamine
Dopamine PDE-3 Inhibitors |
|
What is the end result when using Dobutamine in a Stage D HF patient?
|
Increased force of contraction (+ ionotrope) without significantly increasing HR
|
|
What is the main MOA in which Dobutamine treats HF?
|
Activates β1 receptors
Increased force of contraction (+ ionotropic effect) |
|
Dobutamine activates which receptors?
|
β1 > β2 > α
|
|
What receptors does Dopamine activate?
|
Lower dose ------------------High dose
dopaminergic___β________α |
|
Low dose Dopamine's MOA in HF?
|
Activates dopaminergic (DA) receptors
Vasodilation of: -renal a. -splanchnic a. -cerebrospinal a. -coronary blood vessels |
|
What is the end result of Dopamine use in the kidneys?
|
Increased renal bloodflow
Increased Urine Output |
|
MOA Higher doses of Dopamine to treat HF?
|
Activates β1 receptors on heart
Increases HR (+ ionotropic effect) |
|
What drug is useful in episodes of cardiogenic shock where BP and CO are very low?
|
Highest doses of dopamine
Activate α1 receptors ---> VC arteries INCREASE BP |
|
MOA PDE-3 inhibitors in HF
|
Inhibit PDE-3
↑cAMP leads to: - ↑ force of contraction - ↑Velocity of relaxation (↑filling) -Vasodilation (+ ionotropic drug) |
|
Can PDE-3 inhibitors be used chronically?
|
NO!
Increased Mortality with longterm use!! |
|
What are some intolerable side effects of PDE-3 inhibitor use?
|
Inamrinone --> thrombocytopenia
Both --> hypotension, arrythmias |
|
What are + ionotropic drugs used for in treatment of Stage D HF?
|
+ ionotropic drugs only treat symptoms
|
|
Should + ionotropic drugs be used longterm?
|
NO
|
|
Which positive ionotropic drug DOES NOT increase mortality?
|
Digoxin
|